Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.882,94
0,13%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Petros Pharmaceuticals Inc (PTPI) Petros Pharmaceuticals Inc (PTPI) Notizie

PTPI

Petros Pharmaceuticals (PTPI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PTPI
DataOraFonteTitoloSimboloCompagnia
31/05/202423:07Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
21/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
14/05/202413:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202422:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202323:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202322:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202322:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202323:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202323:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202322:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202323:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202323:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202322:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202322:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
29/04/202300:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
22/12/202223:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202214:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202213:03Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:PTPIPetros Pharmaceuticals Inc
21/10/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTPIPetros Pharmaceuticals Inc
14/10/202222:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/10/202223:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
30/09/202222:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/08/202223:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202217:39GlobeNewswire Inc.NOTICE TO DISREGARD - Henry Crown and CompanyNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202216:27GlobeNewswire Inc.Petros Pharmaceuticals Responds to Fraudulent Press ReleaseNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202215:25GlobeNewswire Inc.Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per shareNASDAQ:PTPIPetros Pharmaceuticals Inc
19/07/202215:15GlobeNewswire Inc.Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew PinskyNASDAQ:PTPIPetros Pharmaceuticals Inc
16/05/202223:00GlobeNewswire Inc.Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:PTPIPetros Pharmaceuticals Inc
03/05/202215:23GlobeNewswire Inc.Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the USNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202203:25GlobeNewswire Inc.Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022NASDAQ:PTPIPetros Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PTPI

La tua Cronologia

TSX
FFH.PR.M
Fairfax Financial
LSE
80AT
Perm Mast 58 A
BOV
ALLD3R
Allied Tecnologia ON
LSE
80BD
Perm Mast 58 S
TG
TEM
Tongcheng Travel
LSE
52ZK
Wlm Crd 21-1 26
TG
PUM
Puma
BOV
H2TA34M
Healthcare Realty
BOV
CVCB3Q
CVC BRASIL ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network